4
Changes in Ownership
Guardant Health, Inc. Filed Acc 0001968281-26-000012
Director sold 116 shares at $95.96 ($11,131)
- Director acquired 250 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Tariq Musa · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-05-15 | Exercise or conversion : show line 1 in the form 10b5-1 | +250 | 8,778 | D | ||
| 2026-05-18 | Sale : show line 2 in the form 10b5-1 | −116 | $95.96 | $11,131 | 8,662 | D |
| Open-market sales · 116 sh · avg $95.96 · $11,131 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-05-15 | Exercise or conversion : show line 3 in the form 10b5-1 Restricted Stock Units | −250 | 2,499 | D |
Loading xslF345X06/wk-form4_1779228137.xml…